The HIV care cascade: models, measures and moving forward

Sarah MacCarthy, Michael Hoffmann, Laura Ferguson, Amy Nunn, Risha Irvin, David Bangsberg, Sofia Gruskin, Ines Dourado, Sarah MacCarthy, Michael Hoffmann, Laura Ferguson, Amy Nunn, Risha Irvin, David Bangsberg, Sofia Gruskin, Ines Dourado

Abstract

Introduction: This article seeks to identify where delays occur along the adult HIV care cascade ("the cascade"), to improve understanding of what constitutes "delay" at each stage of the cascade and how this can be measured across a range of settings and to inform service delivery efforts. Current metrics are reviewed, measures informed by global guidelines are suggested and areas for further clarification are underscored.

Discussion: Questions remain on how best to evaluate late entry into each stage of the cascade. The delayed uptake of HIV testing may be more consistently measured once rapid CD4 testing is administered at the time of HIV testing. For late enrollment, preliminary research has begun to determine how different time intervals for linking to HIV care affect individual health. Regarding treatment, since 2013, the World Health Organization (WHO) and UNAIDS recommend treatment initiation when CD4 <500 cells/mm(3); these guidelines provide a useful albeit evolving threshold to define late treatment initiation. Finally, WHO guidelines for high-, low- and middle-income countries also could be used to standardize measures for achieving viral suppression.

Conclusions: There is no "one size fits all" model as the provision of services may differ based on a range of factors. Nonetheless, measures informed by global guidelines are needed to more consistently evaluate the scope of and factors associated with delays to each stage of the cascade. Doing so will help identify how practitioners can best deliver services and facilitate access to and continued engagement in care.

Keywords: HIV/AIDS; care cascade; continuum of care; linkage to care; measures; testing; treatment cascade; viral suppression.

References

    1. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.
    1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.
    1. HIV/AIDS Care Continuum: U.S. Department of Health and Human Services. 2013. [cited 2014 April 14]. Available from:
    1. Kozak M, Zinski A, Leeper C, Willig JH, Mugavero MJ. Late diagnosis, delayed presentation and late presentation in HIV: proposed definitions, methodological considerations and health implications. Antivir Ther. 2013;18(1):17–23.
    1. Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis. 2013;57(8):1164–71.
    1. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8(7):e1001056.
    1. Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health. 2012;17(12):1509–20.
    1. HIV in the United States: the stages of care. CDC Fact Sheet. [Internet]. 2012. [cited 2014 April 14]. Available from: .
    1. Pérez MJ, Sayles J, Kulkarni S. HIV prevention through care and treatment. In: County of Los Angeles Public Health Division of HIV and STD Programs, editor. Los Angeles: Erase Doubt; 2012.
    1. British HIV Association. London: British HIV Association; 2012. Standards of care for people living with HIV 2013.
    1. Brazilian Ministry of Health. Brasília, Brazil: Department of Sexually Transmitted Diseases and HIV/AIDS; 2013. Epidemiologic Bulletin: HIV/AIDS.
    1. World Health Organization. Geneva, Switzerland: World Health Organization; 2013. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach.
    1. McMahon JH, Elliott JH, Bertagnolio S, Kubiak R, Jordan MR. Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review. Bull World Health Organ. 2013;91(5):377–85E.
    1. World Health Organization. Geneva, Switzerland: World Health Organization; 2012. Handbook for guideline development.
    1. Nhac-Vu HT, Giard M, Phong ND, Vanhems P. Risk factors for delayed HIV diagnosis at the Hospital of Tropical Diseases in Ho Chi Minh City, Vietnam. Int J STD AIDS. 2010;21(12):802–5.
    1. Oliva J, Galindo S, Vives N, Arrillaga A, Izquierdo A, Nicolau A, et al. [Delayed diagnosis of HIV infection in Spain] Enferm Infecc Microbiol Clin. 2010;28(9):583–9.
    1. Delpierre C, Dray-Spira R, Cuzin L, Marchou B, Massip P, Lang T, et al. Correlates of late HIV diagnosis: implications for testing policy. Int J STD AIDS. 2007;18(5):312–7.
    1. Carrizosa CM, Blumberg EJ, Hovell MF, Martinez-Donate AP, Garcia-Gonzalez G, Lozada R, et al. Determinants and prevalence of late HIV testing in Tijuana, Mexico. AIDS Patient Care STDS. 2010;24(5):333–40.
    1. Mugavero MJ, Castellano C, Edelman D, Hicks C. Late diagnosis of HIV infection: the role of age and sex. Am J Med. 2007;120(4):370–3.
    1. Centers for Disease Control and Prevention (CDC) Late HIV testing – 34 states, 1996–2005. MMWR Morb Mortal Wkly Rep. 2009;58(24):661–5.
    1. Grigoryan A, Hall HI, Durant T, Wei X. Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996–2004. PLoS One. 2009;4(2):e4445.
    1. Schwarcz SK, Hsu L, Chin CS, Richards TA, Frank H, Wenzel C, et al. Do people who develop AIDS within 12 months of HIV diagnosis delay HIV testing? Public Health Rep. 2011;126(4):552–9.
    1. Sobrino-Vegas P, Garcia-San Miguel L, Caro-Murillo AM, Miro JM, Viciana P, Tural C, et al. Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality. Curr HIV Res. 2009;7(2):224–30.
    1. Wohl AR, Tejero J, Frye DM. Factors associated with late HIV testing for Latinos diagnosed with AIDS in Los Angeles. AIDS Care. 2009;21(9):1203–10.
    1. Crawford TN, Sanderson WT, Thornton A. A comparison study of methods for measuring retention in HIV medical care. AIDS Behav. 2013;17(9):3145–51.
    1. Keller SC, Yehia BR, Eberhart MG, Brady KA. Accuracy of definitions for linkage to care in persons living with HIV. J Acquir Immune Defic Syndr. 2013;63(5):622–30.
    1. Mugavero MJ, Westfall AO, Zinski A, Davila J, Drainoni ML, Gardner LI, et al. Measuring retention in HIV care: the elusive gold standard. J Acquir Immune Defic Syndr. 2012;61(5):574–80.
    1. Yehia BR, French B, Fleishman JA, Metlay JP, Berry SA, Korthuis PT, et al. Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts. J Acquir Immune Defic Syndr. 2014;65(3):333–9.
    1. World Health Organization and UNAIDS. Geneva, Switzerland: World Health Organization and UNAIDS; 2013. Technical update on HIV incidence assays for surveillance and epidemic monitoring.
    1. Cairns G. London, England: AIDSmap; 2014. Can we provide point-of-care viral load tests in poor countries?
    1. World Health Organization. Geneva, Switzerland: World Health Organization; 2014. March 2014 Supplement to the 2013 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection.
    1. Tanner AE, Muvva R, Miazad R, Johnson S, Burnett P, Olthoff G, et al. Integration of HIV testing and linkage to care by the Baltimore City Health Department. Sex Transm Dis. 2010;37(2):129–30.
    1. Kohler PK, Chung MH, McGrath CJ, Benki-Nugent SF, Thiga JW, John-Stewart GC. Implementation of free cotrimoxazole prophylaxis improves clinic retention among antiretroviral therapy-ineligible clients in Kenya. AIDS. 2011;25(13):1657–61.
    1. Holmes CB. Using the side door: non-linear patterns within the HIV treatment cascade in Zambia. Conference on Retroviruses and Opportunistic Infections (CROI); Mar 3–6; Boston, MA: 2013.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅